Aethlon Medical (AEMD) Liabilities and Shareholders Equity (2016 - 2024)
Aethlon Medical (AEMD) has disclosed Liabilities and Shareholders Equity for 14 consecutive years, with $6.5 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Liabilities and Shareholders Equity fell 37.48% year-over-year to $6.5 million, compared with a TTM value of $26.8 million through Mar 2025, down 43.38%, and an annual FY2024 reading of $8.2 million, down 52.9% over the prior year.
- Liabilities and Shareholders Equity was $6.5 million for Q4 2024 at Aethlon Medical, down from $8.8 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $25.9 million in Q2 2021 and bottomed at $6.5 million in Q4 2024.
- Average Liabilities and Shareholders Equity over 5 years is $15.4 million, with a median of $15.4 million recorded in 2020.
- The sharpest move saw Liabilities and Shareholders Equity soared 1074.64% in 2020, then tumbled 52.9% in 2024.
- Year by year, Liabilities and Shareholders Equity stood at $12.7 million in 2020, then skyrocketed by 72.98% to $21.9 million in 2021, then fell by 5.44% to $20.7 million in 2022, then tumbled by 49.64% to $10.4 million in 2023, then plummeted by 37.48% to $6.5 million in 2024.
- Business Quant data shows Liabilities and Shareholders Equity for AEMD at $6.5 million in Q4 2024, $8.8 million in Q3 2024, and $11.4 million in Q2 2024.